148 related articles for article (PubMed ID: 3383752)
1. Terodiline and oxybutynin in detrusor instability.
Drug Ther Bull; 1988 May; 26(10):37-8. PubMed ID: 3383752
[No Abstract] [Full Text] [Related]
2. Functional daytime incontinence: pharmacological treatment.
Hjälmås K; Passerini-Glazel G; Chiozza ML
Scand J Urol Nephrol Suppl; 1992; 141():108-14; discussion 115-6. PubMed ID: 1609246
[TBL] [Abstract][Full Text] [Related]
3. The effect of terodiline on patients with detrusor instability.
Macfarlane JR; Tolley DA
Scand J Urol Nephrol Suppl; 1984; 87():51-4. PubMed ID: 6399954
[TBL] [Abstract][Full Text] [Related]
4. A calcium blocking and anticholinergic agent (terodiline) in the treatment of detrusor hyperreflexia: a placebo-controlled, cross-over trial.
Petersen T; Jakobsen J
J Neurol Neurosurg Psychiatry; 1987 Oct; 50(10):1331-6. PubMed ID: 3681312
[TBL] [Abstract][Full Text] [Related]
5. [Instability of the detrusor muscle. Treatment with oxybutynin chloride (ditropan)].
Perales Cabanas L; Tallada Buñuel M; Romero Maroto J; Escribano Patiño G
Actas Urol Esp; 1986; 10(6):481-6. PubMed ID: 3825651
[No Abstract] [Full Text] [Related]
6. [Clinical study of terodiline hydrochloride for the treatment of urinary frequency and urinary incontinence, and its cardiovascular adverse effects].
Yoshihara H; Yasumoto R; Kishimoto T; Maekawa M; Horii A; Nishijima T; Sugimoto T; Kashiwara N; Tsujita M; Senjyu M
Hinyokika Kiyo; 1992 Aug; 38(8):967-72. PubMed ID: 1414748
[TBL] [Abstract][Full Text] [Related]
7. Terodiline in the treatment of urinary frequency and motor urge incontinence. Workshop in Düsseldorf, August 28-29, 1983.
Scand J Urol Nephrol Suppl; 1984; 87():1-61. PubMed ID: 6399952
[No Abstract] [Full Text] [Related]
8. [Terodiline in the treatment of stress incontinence in women].
Feyereisl J; Hänggi W; Dreher E
Schweiz Rundsch Med Prax; 1990 Apr; 79(14):420-2. PubMed ID: 2343228
[TBL] [Abstract][Full Text] [Related]
9. Terodiline: a new compound for the treatment of urge incontinence.
Wroblewski J
Ostomy Wound Manage; 1990; 30():22-9. PubMed ID: 2080974
[No Abstract] [Full Text] [Related]
10. [Clinical evaluation of long-term administration of terodiline hydrochloride for the treatment of patients with pollakisuria and incontinence].
Tsujimoto Y; Fujisue H; Shima H; Ikoma F; Sakurai T; Sato Y; Tokizane M; Akiyama K; Kato S; Nakachi K
Hinyokika Kiyo; 1988 Apr; 34(4):724-32. PubMed ID: 3400552
[TBL] [Abstract][Full Text] [Related]
11. Oxybutynin chloride in the management of idiopathic detrusor instability.
Paulson DF
South Med J; 1979 Mar; 72(3):374-5. PubMed ID: 424842
[No Abstract] [Full Text] [Related]
12. Bladder training and terodiline in females with idiopathic urge incontinence and stable detrusor function.
Klarskov P; Gerstenberg TC; Hald T
Scand J Urol Nephrol; 1986; 20(1):41-6. PubMed ID: 3704568
[TBL] [Abstract][Full Text] [Related]
13. The treatment of detrusor instability in postmenopausal women with oxybutynin chloride: a double blind placebo controlled study.
Moore KH; Goldstein M; Hay D
Br J Obstet Gynaecol; 1990 Nov; 97(11):1063-4. PubMed ID: 2082973
[No Abstract] [Full Text] [Related]
14. Oxybutynin hydrochloride in the management of detrusor instability.
Primus G; Pummer K
Int Urol Nephrol; 1990; 22(3):243-8. PubMed ID: 2210980
[TBL] [Abstract][Full Text] [Related]
15. Concentration dependent cardiotoxicity of terodiline in patients treated for urinary incontinence.
Thomas SH; Higham PD; Hartigan-Go K; Kamali F; Wood P; Campbell RW; Ford GA
Br Heart J; 1995 Jul; 74(1):53-6. PubMed ID: 7662454
[TBL] [Abstract][Full Text] [Related]
16. [Oxybutynin chloride in pediatrics: extenuating circumstances].
Aubert D
Arch Fr Pediatr; 1988 May; 45(5):375-6. PubMed ID: 3415420
[No Abstract] [Full Text] [Related]
17. [Clinical effects of terodiline hydrochloride for urinary frequency and sense of residual urine].
Fujiwara E; Nakano H; Nihira H; Kitano T; Ukai R; Masu C; Onishi Y; Kodama M; Hatachi K; Matsuki A
Hinyokika Kiyo; 1988 Apr; 34(4):733-8. PubMed ID: 3400553
[TBL] [Abstract][Full Text] [Related]
18. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
Goldenberg MM
Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730
[TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of long-term administration with terodiline hydrochloride for the treatment of patients with neurogenic bladder].
Ishido T; Miyazaki K
Hinyokika Kiyo; 1988 Apr; 34(4):754-8. PubMed ID: 3400554
[TBL] [Abstract][Full Text] [Related]
20. Terodiline. A review of its pharmacological properties, and therapeutic use in the treatment of urinary incontinence.
Langtry HD; McTavish D
Drugs; 1990 Nov; 40(5):748-61. PubMed ID: 2292235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
